Current role
James J. Ferguson, MD
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James J. Ferguson, MD
Cadrenal Therapeutics, Inc. reported in an 8-K filed February 7, 2025 that James J. Ferguson, MD was appointed Chief Medical Officer, effective February 6, 2025.
“Cadrenal TherapeuticsAnnounces Chief Medical Officer Transition to Advance Clinical Development of Tecarfarin”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-02-06–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cadrenal Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- John P. Sharp CFO
- Matthew K. Szot CFO
- Quang X. Pham CFO, Chief Accounting Officer, Board Member
- Jeffrey Cole COO
- Class I Directors Board Member
- Glynn Wilson Board Member
- John Murphy Board Member
- Lee Golden Board Member
- Lee Scott Golden, M.D. Board Member
- Robert Lisicki Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.